血浆自身抗体作为卒中新型风险标志物:JPHC研究巢式病例对照分析
在日本公共卫生中心前瞻性研究(JPHC)32,527名40-69岁人群中开展巢式病例对照研究,检测38种动脉粥样硬化相关新型自身抗体,比较371例卒中病例(203例缺血性、168例出血性)与371名匹配对照。
要点
- 关联在缺血性卒中中方向相似但较弱,出血性卒中未见关联。
- 自身抗体或可作为未来卒中发病的预测标志物。
核心结论
- 这些新型自身抗体具有预测未来卒中发病的潜力。
研究设计与样本
- 在日本公共卫生中心前瞻性研究内开展巢式病例对照研究,基线为1990-1993年40-69岁日本人群32,527名,随访至2007年底。
- 检测38种动脉粥样硬化相关新型自身抗体的血浆水平,采用 amplified luminescent proximity homogeneous assay-linked immunosorbent assay 方法。
- 纳入371例卒中病例(203例缺血性、168例出血性)和371名按年龄、性别和社区匹配的对照。
主要发现
- 调整主要心血管危险因素后,抗DIDO1肽、抗LIMA1肽、抗SH3BP5肽、抗FOXJ2肽、抗KIF20B蛋白、抗DIDO1蛋白、抗TPM3蛋白、抗COPE蛋白、抗MMP1蛋白和抗IFI16肽自身抗体与总卒中风险显著相关,最高vs最低四分位OR≥1.63。
- 上述关联在缺血性卒中中方向总体相似但较弱,在出血性卒中中未观察到。
临床怎么用
- 这些自身抗体有望作为社区人群未来卒中发病的风险预测标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Recent reports have shown the development of autoantibodies in patients with atherosclerosis. The purpose of this study is to examine whether these autoantibodies are associated with the risk of incident stroke in community-based population. METHODS: We performed a nested case-control study within the Japan Public Health Center-based Prospective Study involving 32,527 Japanese individuals aged 40-69 years at baseline (1990-1993). Incident stroke was followed up until the end of 2007. We identified 38 novel autoantibody biomarkers for atherosclerosis, and the plasma levels of these autoantibodies were measured by use of amplified luminescent proximity homogeneous assay-linked immunosorbent assay methods in 371 stroke cases (203 ischemic and 168 hemorrhagic) and 371 age-, sex-, and community-matched controls. Conditional odds ratios of total, ischemic, and hemorrhagic strokes according to quartiles of each autoantibody were calculated after adjustment for major cardiovascular risk factors. RESULTS: Of the 38 the novel autoantibodies, the levels of anti-DIDO1 peptide, anti-LIMA1 peptide, anti-SH3BP5 peptide, anti-FOXJ2 peptide, anti-KIF20B protein, anti-DIDO1 protein, anti-TPM3 protein, anti-COPE protein, anti-MMP1 protein and anti-IFI16 peptide autoantibodies were significantly associated with the risk of total stroke (odds ratios of the highest versus lowest quartile ≥1.63) after adjustment for major cardiovascular risk factors. The association was generally similar but weakly observed for ischemic stroke but not for hemorrhagic stroke. CONCLUSIONS: These novel autoantibodies have the potential to predict future stroke incidence.
引用
- Yamagishi K, Hiwasa T, Sun W, et al. Plasma autoantibodies as novel risk markers for stroke: A nested case-control study of the JPHC study. Clin Chim Acta. 2026. PMID: 42225204. doi:10.1016/j.cca.2026.121121
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。